News + Updates
GHO Capital announces two acquisitions to create pan-European ophthalmic specialty pharmaceutical company
Ken Eichmann joins GHO Capital as Principal
GHO Capital acquires Quotient Clinical
GHO Capital announces acquisition of DNA Diagnostics Center
GHO Capital supports European Medicines Agency’s “Science, Medicines, Health: Patients at the heart of future innovation” conference
Load more